Recent Advances in Therapeutic Antibody Screening
This article explores the various screening technologies used in the development of therapeutic antibodies and outlines the recent advances in this area.
Protein Hyperactivation Could Kill Cancer Cells and Bacteria
Technology Networks had the pleasure of speaking with Walid A. Houry, professor of biochemistry at the University of Toronto, to find out about the discovery of compounds that can induce protease hyperactivation to kill cancer cells.
Septic Shock and Metastases: Finding the Culprits
A new molecule, based on the anti-diabetes drug metformin, can bind copper, found to be important in acute inflammation, sepsis and cancer dissemination, and thus holds great promise for new therapy.
Improving Image Integrity in Scientific Papers
This article sheds light on the issue of image integrity in academic publishing and gives advice on how to reduce the risk.
Improving Time-to-Value for GxP Computer Systems
Jim Brooks shares top tips to overcome the biggest validation challenges and best practices for building and implementing a digital process data strategy to lead to smarter and faster validation.
The Pulse: Psychedelic News From Technology Networks Issue 3
Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.
Silencing the Storm: Could Psychedelics Change How We Treat Migraine and Cluster Headache?
Emerging clinical trial data suggest that psychedelic compounds could benefit both millions of migraineurs and thousands of cluster headache sufferers who find limited benefit from even gold-standard treatments.
The Impact of UK Collaboration in Life Sciences
In this opinion piece, Jan Wauters discusses why collaboration in science is so important and what the Windsor Framework could mean for research in Europe.
Bringing the Beauty of Dissolution to the World of Medical Devices
Products coated with a small amount of drug that releases over an extended period of time aren’t suitable for traditional dissolution testing. Therefore, novel drug delivery mechanisms and devices require a new approach to this regulated technique.
The Role of Smart Technology in Mitigating the Risk of Human Error and Improving Productivity in Pharmaceutical Quality Control
In this article, discover the role HPLC plays in ensuring regulatory compliance and reliability of throughput, and how labs can automate to eliminate errors and build reliability into their processes.